Psychotic Disorders (epidemiology) < Psychotic Disorders (etiology) < Psychotic Disorders (genetics)

Facettes :

List of bibliographic references indexed by Psychotic Disorders (etiology)

Number of relevant bibliographic references: 20.

Ident.	Authors (with country if any)	Title
000D16 (2012)	Joseph H. Friedman	Melperone is ineffective in treating Parkinson's disease psychosis.
001483 (2011)	Daniel Weintraub [États-Unis] ; David J. Burn [Royaume-Uni]	Parkinson's disease: The quintessential neuropsychiatric disorder
001697 (2011)	Stewart A. Factor [États-Unis] ; N. Kyle Steenland [États-Unis] ; Donald S. Higgins [États-Unis] ; Eric S. Molho [États-Unis] ; Denise M. Kay [États-Unis] ; Jennifer Montimurro [États-Unis] ; Ami R. Rosen [États-Unis] ; Cyrus P. Zabetian [États-Unis] ; Haydeh Payami [États-Unis]	Disease‐related and genetic correlates of psychotic symptoms in Parkinson's disease
001B08 (2010)	Tiffini S. Voss [États-Unis] ; Alicia F. D. Brocht [États-Unis] ; Bernard Ravina [États-Unis]	Performance of the scale for assessment of positive symptoms in Parkinson's disease psychosis
001D68 (2010)	Javier Virués-Ortega [Espagne] ; Carmen Rodríguez-Blázquez [Espagne] ; Federico Micheli [Argentine] ; Francisco Javier Carod-Artal [Brésil] ; Marcos Serrano-Due As [Équateur] ; Pablo Martínez-Martín [Espagne]	Cross‐cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages
002108 (2009)	Dagmar Verbaan [Pays-Bas] ; Stephanie M. Van Rooden [Pays-Bas] ; Martine Visser [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Murat Emre [Turquie] ; Jacobus J. Van Hilten [Pays-Bas]	Psychotic and compulsive symptoms in Parkinson's disease
002635 (2008)	Hubert H. Fernandez [États-Unis] ; Dag Aarsland [Norvège] ; Gilles Fénelon [France] ; Joseph H. Friedman [États-Unis] ; Laura Marsh [États-Unis] ; Alexander I. Tröster [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis]	Scales to assess psychosis in Parkinson's disease: Critique and recommendations
002831 (2008)	Jonathan T. Stewart [États-Unis]	Frégoli syndrome associated with levodopa treatment
002B64 (2007)	Kazuaki Kanai [Japon] ; Ryuji Sakakibara [Japon] ; Tomoyuki Uchiyama [Japon] ; Zhi Liu [Japon] ; Tatsuya Yamamoto [Japon] ; Takashi Ito [Japon] ; Shigeki Hirano [Japon] ; Masato Asahina [Japon] ; Satoshi Kuwabara [Japon] ; Takamichi Hattori [Japon] ; Goro Fukami [Japon] ; Kimihito Arai [Japon] ; Chiharu Yamaguchi [Japon] ; Fumio Nomura [Japon]	Sporadic case of spinocerebellar ataxia type 17: Treatment observations for managing urinary and psychotic symptoms
002E10 (2007)	Sabrina Paganoni [États-Unis] ; Andrew M. Naidech [États-Unis] ; Puneet Opal [États-Unis]	Huntington's disease presenting as postsurgical psychosis
003011 (2007)	Martine Visser [Pays-Bas] ; Dagmar Verbaan [Pays-Bas] ; Stephanie M. Van Rooden [Pays-Bas] ; Anne M. Stiggelbout [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas]	Assessment of psychiatric complications in Parkinson's disease: The SCOPA‐PC
003017 (2007)	Connie Marras [Canada] ; Alexander Kopp [Canada] ; Feng Qiu [Canada] ; Anthony E. Lang [Canada] ; Kathy Sykora [Canada] ; Kenneth I. Shulman [Canada] ; Paula A. Rochon [Canada]	Antipsychotic use in older adults with Parkinson's disease
003277 (2006)	Naomi P. Visanji [Canada] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Donna Pires [Canada] ; Valerie Voon [Canada, États-Unis] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]	Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
003302 (2006)	Joseph H. Friedman [États-Unis] ; Robert M. Berman [États-Unis] ; Christopher G. Goetz [États-Unis] ; Stewart A. Factor [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; William H. Carson [États-Unis] ; Ronald N. Marcus [États-Unis]	Open‐label flexible‐dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
003708 (2005)	Spiridon Papapetropoulos [États-Unis] ; Deborah C. Mash [États-Unis]	The neurochemical mechanism of rebound psychosis in Parkinson's disease
003822 (2005)	Charles H. Adler [États-Unis]	Nonmotor complications in Parkinson's disease
004048 (2003)	Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann [États-Unis] ; Monica A. Burke [États-Unis] ; Carol Jacques [États-Unis] ; Joseph H. Friedman [États-Unis]	Long‐term outcome of quetiapine use for psychosis among parkinsonian patients
004301 (2002)	Stewart A. Factor [États-Unis] ; Eric S. Molho [États-Unis] ; Joseph H. Friedman [États-Unis]	Risperidone and parkinson's disease
004494 (2002)		Drugs to treat dementia and psychosis
004692 (2001)	Paul J. Reading [Royaume-Uni] ; Anna K. Luce [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni]	Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Psychotic Disorders (etiology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Psychotic Disorders (etiology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Psychotic Disorders (etiology)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024